GO
Loading...

Health Care Equipment and Supplies

More

  • Midday Glance: Medical Devices companies Thursday, 29 Jan 2015 | 1:23 PM ET

    Allergan fell $1.30 or. 6 percent, to $221.06. Baxter International Inc. rose$. 68 or 1.0 percent, to $70.84. Boston Scientific Corp. rose$. 04 or. 3 percent, to $14.63.

  • Early Glance: Medical Devices companies Thursday, 29 Jan 2015 | 10:40 AM ET

    Allergan fell$. 80 or. 4 percent, to $221.56. Baxter International Inc. rose$. 57 or. 8 percent, to $70.73. St. Jude Medical Inc. fell$. 86 or 1.3 percent, to $66.53.

  • 2015's strong outlook for healthcare IPOs  Thursday, 29 Jan 2015 | 5:40 AM ET

    Cathrin Petty, co-head of EMEA healthcare at JP Morgan, says the U.K. has the capacity to be a successful market for life sciences, and the year ahead for healthcare IPOs looks strong.

  • The rise and rise of life sciences  Thursday, 29 Jan 2015 | 4:55 AM ET

    George Freeman MP, minister of life sciences in the U.K., says there's been a "resurgence" for life sciences and healthcare investment.

  • NEW YORK, Jan 29- When Marty Weinstein decided to quit smoking, he took a friend's advice and tried electronic cigarettes rather than government-approved nicotine replacement products. E-cigarette makers in the United States are barred from explicitly marketing the products as smoking cessation devices, but have found ways to appeal legally to smokers who...

  • Final Glance: Medical Devices companies Wednesday, 28 Jan 2015 | 6:07 PM ET

    Allergan fell $3.39 or 1.5 percent, to $222.36. Baxter International Inc. fell$. 50 or. 7 percent, to $70.16. Boston Scientific Corp. fell$. 15 or 1.0 percent, to $14.59.

  • Midday Glance: Medical Devices companies Wednesday, 28 Jan 2015 | 1:21 PM ET

    Allergan fell$. 92 or. 4 percent, to $224.83. Baxter International Inc. rose$. 17 or. 2 percent, to $70.83. Boston Scientific Corp. rose$. 01 or percent, to $14.75.

  • Abiomed hits all-time high on sales, new device clearance Wednesday, 28 Jan 2015 | 12:49 PM ET

    NEW YORK— Shares of Abiomed surged to an all-time high Wednesday after posting strong third-quarter results and gaining marketing approval for a new heart device. The Food and Drug Administration granted a humanitarian device exemption for Abiomed's Impella RP, meaning it can be put into use without typical delays. Abiomed Inc. also topped Wall Street...

  • WASHINGTON— The Food and Drug Administration said Wednesday it will require makers of heart-zapping defibrillators to submit more data on the emergency devices after years of recalls and manufacturing problems. Additionally, the FDA will inspect manufacturing plants before companies can begin marketing new devices. The FDA says it has received 72,000...

  • Early Glance: Medical Devices companies Wednesday, 28 Jan 2015 | 10:41 AM ET

    Allergan rose$. 09 or percent, to $225.84. Baxter International Inc. rose$. 27 or. 4 percent, to $70.93. Boston Scientific Corp. rose$. 09 or. 6 percent, to $14.83.

  • Jan 27- Medical device maker Abiomed Inc raised its full-year revenue forecast and said the U.S. Food and Drug Administration had approved its heart pump, sending its stock nearly 32 percent in extended trading. Abiomed's heart pump, Impella RP, helps blood circulation for up to 14 days in patients who develop acute right heart failure following implantation,...

  • Final Glance: Medical Devices companies Tuesday, 27 Jan 2015 | 6:08 PM ET

    Allergan fell $2.08 or. 9 percent, to $225.75. Baxter International Inc. fell$. 22 or. 3 percent, to $70.66. Boston Scientific Corp. fell$. 22 or 1.5 percent, to $14.74.

  • Jan 27- Medical device maker Abiomed Inc raised its full-year revenue forecast and said it had received U.S. approval for its heart pump, sending its stock soaring 24 percent after-hours. Abiomed raised its revenue estimate for the year ending March 31 to $223- $226 million from $209- $212 million. The company said the U.S. Food and Drug Administration had approved...

  • Midday Glance: Medical Devices companies Tuesday, 27 Jan 2015 | 1:36 PM ET

    Allergan fell $1.01 or. 4 percent, to $226.82. Baxter International Inc. fell$. 10 or. 1 percent, to $70.78. Johnson& Johnson fell$. 25 or. 2 percent, to $102.01.

  • Early Glance: Medical Devices companies Tuesday, 27 Jan 2015 | 10:25 AM ET

    Allergan fell$. 91 or. 4 percent, to $226.92. Baxter International Inc. fell$. 27 or. 4 percent, to $70.61. Boston Scientific Corp. fell$. 16 or 1.1 percent, to $14.80.

  • Final Glance: Medical Devices companies Monday, 26 Jan 2015 | 6:04 PM ET

    Allergan rose $3.66 or 1.6 percent, to $227.83. Baxter International Inc. fell$. 55 or. 8 percent, to $70.88. Boston Scientific Corp. rose$. 12 or. 8 percent, to $14.96.

  • Midday Glance: Medical Devices companies Monday, 26 Jan 2015 | 1:53 PM ET

    Allergan rose $2.55 or 1.1 percent, to $226.72. Baxter International Inc. fell$. 59 or. 8 percent, to $70.84. Boston Scientific Corp. fell$. 05 or. 3 percent, to $14.79.

  • Early Glance: Medical Devices companies Monday, 26 Jan 2015 | 12:16 PM ET

    Allergan rose$. 81 or. 4 percent, to $224.98. Baxter International Inc. fell$. 58 or. 8 percent, to $70.85. Boston Scientific Corp. fell$. 12 or. 8 percent, to $14.72.

  • Final Glance: Medical Devices companies Friday, 23 Jan 2015 | 6:04 PM ET

    Allergan rose $1.38 or. 6 percent, to $224.17. Baxter International Inc. fell$. 83 or 1.1 percent, to $71.43. Boston Scientific Corp. fell$. 09 or. 6 percent, to $14.84.

  • Midday Glance: Medical Devices companies Friday, 23 Jan 2015 | 1:31 PM ET

    Allergan rose$. 72 or. 3 percent, to $223.51. Baxter International Inc. fell$. 35 or. 5 percent, to $71.91. Boston Scientific Corp. fell$. 03 or. 2 percent, to $14.90.